The Federal University of Goiás is a publicly funded university located in the Brazilian state of Goiás, headed in Goiânia and with campuses in the municipalities of Catalão, City of Goiás, and Jataí.

During the past decade, Universidade Federal de Goias conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universidade Federal de Goias" #1 sponsor was "Hospital Israelita Albert Einstein" with 3 trials, followed by "Universidade Federal de Goias" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "University of Campinas, Brazil" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidade Federal de Goias" #1 collaborator was "Ministry of Health, Brazil" with 3 trials as a collaborator, "Federal University of São Paulo" with 1 trials as a collaborator and "Goiania Municipal Health Department" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Universidade Federal de Goias" are "Cognitive Impairment" (2 trials), "Heart Failure With Preserved Ejection Fraction" (2 trials), "Acute Coronary Syndrome" (1 trials), "Anemia" (1 trials) and "Blood Pressure" (1 trials). Many other conditions were trialed in "Universidade Federal de Goias" in a lesser frequency.

Most popular intervention types in "Universidade Federal de Goias" are "Drug" (8 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Intensive Control of Systolic Blood Pressure (SBP)" (2 trials), "Standard control of Systolic Blood Pressure (SBP)" (2 trials), "Active Comparator: Timolol 0.5%" (1 trials) and "Antiplatelet Monotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universidade Federal de Goias" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Universidade Federal de Goias". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universidade Federal de Goias, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universidade Federal de Goias, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Universidade Federal de Goias has several departments that took part in Clinical trials: "School of Dentistry, Federal University of Goias" - 5 trials, "Hospital das Clinicas - UFG;Reumatologia" - 3 trials